Relapsing and refractory myeloma present unique challenges for patients and their healthcare teams. In this session from the Myeloma UK London Infoday 2024, experts discuss strategies for managing myeloma when it becomes resistant to treatment or returns after remission.
📌 What you'll learn:
Understanding relapsing and refractory myeloma
Treatment options for managing disease progression
Insights into emerging therapies and clinical trials
This session offers valuable information for patients, caregivers, and healthcare professionals navigating advanced stages of myeloma.
🔗 Learn more: www.myeloma.org.uk
👍 Like, comment, and subscribe to stay informed!
#MyelomaUK #Infoday2024 #RelapsingMyeloma #RefractoryMyeloma
